Angiogenin expression in human kidneys and Wilms' tumours: Relationship with hypoxia and angiogenic factors

International Journal of Experimental Pathology

Volumn 94, Issue 2, 2013, Pages 115-125

  Ramani, Pramila ^a,b   Headford, Alison ^a   Sowa Avugrah, Emile ^a   Hunt, Linda P ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Angiogenesis; Angiogenin; Human kidney; Hypoxia; Lactate dehydrogenase A; Wilms' tumour

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; ANTINEOPLASTIC AGENT; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR E40; LACTATE DEHYDROGENASE ISOENZYME 5; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CELLULAR DISTRIBUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY; KIDNEY BLOOD VESSEL; KIDNEY PROXIMAL TUBULE; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

ANGIOGENESIS; ANGIOGENIN; HUMAN KIDNEY; HYPOXIA; LACTATE DEHYDROGENASE A; WILMS' TUMOUR;

ANGIOGENESIS INDUCING AGENTS; ANOXIA; ANTIGENS, CD31; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHILD; CLUSTER ANALYSIS; FEMALE; FETUS; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; ISOENZYMES; KIDNEY; L-LACTATE DEHYDROGENASE; PREGNANCY; RIBONUCLEASE, PANCREATIC; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WILMS TUMOR;

EID: 84875055059     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12012     Document Type: Article

References (57)

1. Abramson L.P., Grundy P.E., Rademaker A.W. et al. (2003) Increased microvascular density predicts relapse in Wilms' tumor. J. Pediatr. Surg. 38, 325-330.
2. Beckwith J.B., Kiviat N.B., Bonadio J.F. (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr. Pathol. 10, 1-36.
3. Bergers G. & Benjamin L.E. (2003) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401-410.
4. Bernhardt W.M., Schmitt R., Rosenberger C. et al. (2006) Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int. 69, 114-122.
5. Campo L., Turley H., Han C. et al. (2005) Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. J. Pathol. 205, 585-591.
6. Chakrabarti J., Turley H., Campo L. et al. (2004) The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br. J. Cancer 91, 954-958.
7. Davidoff A.M. (2009) Wilms' tumor. Curr. Opin. Pediatr. 21, 357-364.
8. Dungwa J.V., Hunt L.P., Ramani P. (2011) Overexpression of carbonic anhydrase and HIF-1alpha in Wilms tumours. BMC Cancer 11, 390.
9. Dungwa J.V., Uparkar U., May M.T., Ramani P. (2012) Angiogenin up-regulation correlates with adverse clinicopathological and biological factors, increased microvascular density and poor patient outcome in neuroblastomas. Histopathology 60, 911-923.
10. Freeburg P.B. & Abrahamson D.R. (2003) Hypoxia-inducible factors and kidney vascular development. J. Am. Soc. Nephrol. 14, 2723-2730.
11. Fukuzawa R. & Reeve A.E. (2007) Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. J. Pediatr. Hematol. Oncol. 29, 589-594.
12. Gao X. & Xu Z. (2008) Mechanisms of action of angiogenin. Acta Biochim. Biophys. Sin. (Shanghai) 40, 619-624.
13. Ghanem M.A., van Steenbrugge G.J., Sudaryo M.K., Mathoera R.B., Nijman J.M., van der Kwast T.H. (2003) Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J. Clin. Pathol. 56, 107-113.
14. Ghanem M.A., van der Kwast T.H., Molenaar W.M., Safan M.A., Nijman R.J., van Steenbrugge G.J. (2011) The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful? World J. Urol. doi:10.1007/s00345-011-0684-1.
15. Grath-Morrow S., Cho C., Molls R. et al. (2006) VEGF receptor 2 blockade leads to renal cyst formation in mice. Kidney Int. 69, 1741-1748.
16. Hartmann A., Kunz M., Kostlin S. et al. (1999) Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res. 59, 1578-1583.
17. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 23, 9361-9374.
18. Ivanova A.V., Ivanov S.V., Danilkovitch-Miagkova A., Lerman M.I. (2001) Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway. J. Biol. Chem. 276, 15306-15315.
19. Ivanova A., Liao S.Y., Lerman M.I., Ivanov S., Stanbridge E.J. (2005) STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker. J. Med. Genet. 42, 565-576.
20. Jubb A.M., Buffa F.M., Harris A.L. (2010) Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J. Cell Mol. Med. 14, 18-29.
21. Kaste S.C., Dome J.S., Babyn P.S. et al. (2008) Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr. Radiol. 38, 2-17.
22. Kim H.M., Kang D.K., Kim H.Y., Kang S.S., Chang S.I. (2007) Angiogenin-induced protein kinase B/Akt activation is necessary for angiogenesis but is independent of nuclear translocation of angiogenin in HUVE cells. Biochem. Biophys. Res. Commun. 352, 509-513.
23. Kishimoto K., Liu S., Tsuji T., Olson K.A., Hu G.F. (2005) Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24, 445-456.
24. Kishimoto K., Yoshida S., Ibaragi S. et al. (2012) Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer. Oral Oncol. 48, 1120-1127.
25. Koga K., Osuga Y., Tsutsumi O. et al. (2000) Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J. Clin. Endocrinol. Metab. 85, 3352-3355.
26. Lee Y.M., Jeong C.H., Koo S.Y. et al. (2001) Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev. Dyn. 220, 175-186.
27. Maes P., Delemarre J., de K.J., Ninane J. (1999) Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy. Eur. J. Cancer 35, 1356-1360.
28. Moenner M., Gusse M., Hatzi E., Badet J. (1994) The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur. J. Biochem. 226, 483-490.
29. Moroianu J. & Riordan J.F. (1994a) Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl Acad. Sci. USA 91, 1677-1681.
30. Moroianu J. & Riordan J.F. (1994b) Identification of the nucleolar targeting signal of human angiogenin. Biochem. Biophys. Res. Commun. 203, 1765-1772.
31. Nakamura M., Yamabe H., Osawa H. et al. (2006) Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture. Nephrol. Dial. Transplant. 21, 1489-1495.
32. Olson K.A., Verselis S.J., Fett J.W. (1998) Angiogenin is regulated in vivo as an acute phase protein. Biochem. Biophys. Res. Commun. 242, 480-483.
33. Ozluk Y., Kilicaslan I., Gulluoglu M.G., Ayan I., Uysal V. (2006) The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour. Pathology 38, 408-414.
34. Perez-Ilzarbe M., Agbulut O., Pelacho B. et al. (2008) Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur. J. Heart Fail. 10, 1065-1072.
35. Pilch H., Schlenger K., Steiner E., Brockerhoff P., Knapstein P., Vaupel P. (2001) Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int. J. Gynecol. Cancer 11, 137-142.
36. Pritchard-Jones K., Moroz V., Vujanic G. et al. (2012) Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial. Ann. Oncol. 23, 2457-2463.
37. Rajashekhar G., Loganath A., Roy A.C., Chong S.S., Wong Y.C. (2005) Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts. J. Soc. Gynecol. Investig. 12, 310-319.
38. Rey S. & Semenza G.L. (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc. Res. 86, 236-242.
39. Rivera M.N. & Haber D.A. (2005) Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat. Rev. Cancer 5, 699-712.
40. Rossner M.J., Dorr J., Gass P., Schwab M.H., Nave K.A. (1997) SHARPs: mammalian enhancer-of-split- and hairy-related proteins coupled to neuronal stimulation. Mol. Cell. Neurosci. 9, 460-475.
41. Sebastia J., Kieran D., Breen B. et al. (2009) Angiogenin protects motoneurons against hypoxic injury. Cell Death Differ. 16, 1238-1247.
42. Semenza G.L. (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 33, 207-214.
43. Skoldenberg E.G., Christiansson J., Sandstedt B., Larsson A., Lackgren G., Christofferson R. (2001) Angiogenesis and angiogenic growth factors in Wilms tumor. J. Urol. 165, 2274-2279.
44. Soncin F. (1992) Angiogenin supports endothelial and fibroblast cell adhesion. Proc. Natl Acad. Sci. USA 89, 2232-2236.
45. Takano K., Kawasaki Y., Imaizumi T. et al. (2007) Development of glomerular endothelial cells, podocytes and mesangial cells in the human fetus and infant. Tohoku J. Exp. Med. 212, 81-90.
46. Tello-Montoliu A., Patel J.V., Lip G.Y. (2006) Angiogenin: a review of the pathophysiology and potential clinical applications. J. Thromb. Haemost. 4, 1864-1874.
47. Tsuji T., Sun Y., Kishimoto K. et al. (2005) Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res. 65, 1352-1360.
48. Tufro A., Norwood V.F., Carey R.M., Gomez R.A. (1999) Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J. Am. Soc. Nephrol. 10, 2125-2134.
49. Vallee B.L. & Riordan J.F. (1997) Organogenesis and angiogenin. Cell. Mol. Life Sci. 53, 803-815.
50. Vermeulen P.B., Gasparini G., Fox S.B. et al. (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur. J. Cancer 38, 1564-1579.
51. Verschuur A.C., Vujanic G.M., van T.H., Jones K.P., de K.J., Sandstedt B. (2010) Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience. Pediatr. Blood Cancer 55, 233-238.
52. Vleugel M.M., Greijer A.E., Shvarts A. et al. (2005) Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J. Clin. Pathol. 58, 172-177.
53. Weiner H.L., Weiner L.H., Swain J.L. (1987) Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. Science 237, 280-282.
54. Weis S.M. & Cheresh D.A. (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 17, 1359-1370.
55. Xu Z.P., Tsuji T., Riordan J.F., Hu G.F. (2002) The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem. Biophys. Res. Commun. 294, 287-292.
56. Yamada K. & Miyamoto K. (2005) Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. Front. Biosci. 10, 3151-3171.
57. Yoshioka N., Wang L., Kishimoto K., Tsuji T., Hu G.F. (2006) A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc. Natl Acad. Sci. USA 103, 14519-14524.